Freudly+971 508685814hello@freudly.ai
Freudly

PCOS Type Quiz

PCOS Type Quiz - Free Polycystic Ovarian Test - FreudlyTake a free pcos type quiz to understand your symptoms and pcos type health patterns. Quick, not a diagnosis, consult a specialist. Start now.en
With 15 questions and an estimated completion time of 10 minutes, the PCOS Type Quiz offers a structured look at current androgen-related, menstrual-cycle, and limited metabolic or general-health signals covered by the assessment. Your result can show which domains may merit tracking or follow-up and help you prepare focused questions for a healthcare appointment.
Questions: 1510 minutes
PCOS Type Quiz: situation and reply bubbles
July 22, 2026July 22, 2026Material has been updatedJuly 22, 2026Material has been published
7,134 views
655 completions
552 likes
Daniel HallPsychologist · Test reviewer
552 likes
Scale Explorer

How the Scales are Structured

Androgen-Related PatternsARP
This scale summarizes self-reported patterns often associated with higher androgen effects, such as changes in hair growth, acne, or scalp hair thinning.
example score11/15
11/15Follow-up signalexample score
0No signal noted
1 – 2Noted signal
3 – 15Follow-up signal
A score of 11 falls in the Follow-up signal range, meaning multiple androgen-related patterns were endorsed and may be worth discussing in a clinical context, recognizing this is not diagnostic.
Menstrual-Cycle PatternsMCP
This scale reflects self-reported menstrual-cycle timing and bleeding patterns that may warrant clinical context during a PCOS evaluation.
example score8/15
8/15Follow-up signalexample score
0No signal
1 – 2Noted signal
3 – 15Follow-up signal
A score of 8 falls in the Follow-up signal range, indicating your answers suggest a cycle-related pattern that may be worth discussing with a clinician in context.
Metabolic and General-Health PatternsMaGHP
This scale reflects self-reported metabolic and general-health patterns sometimes discussed during a PCOS evaluation, such as weight change, energy, cravings, and blood-sugar-related symptoms.
example score3/15
3/15Follow-up signalexample score
0No signal noted
1 – 2Noted signal
3 – 15Follow-up signal
A score of 3 falls in the Follow-up signal range, meaning your responses indicated at least one metabolic or general-health pattern that may be worth noting for further evaluation in context.
just completed the test
DATA-BASED USER COHORTS

Who Usually Takes This Test?

Irregular-cycle questioners
41%OF USERS
People with irregular, missed, or very long cycles who want a structured way to reflect on patterns they’ve noticed and what to discuss with a clinician.
Androgen-symptom explorers
34%OF USERS
People dealing with acne, increased facial/body hair, scalp hair thinning, or other androgen-related changes who are curious how these symptoms can cluster.
Metabolic health watchers
25%OF USERS
People concerned about weight changes, insulin resistance, blood sugar issues, or energy crashes who want to see how metabolic signs may overlap with cycle symptoms.
BASED ON AGGREGATED, ANONYMIZED DATA FROM TENS OF THOUSANDS OF FREUDLY USERS.
Benchmarking

See How You Compare

Once you complete the test, your results are compared with real-world data from people in your country.
Below is a preview of how scores are typically distributed across each scale.
Shaded area — where most people score
Dot — the average
You — your score lands on each curve after the test— your score, after the test
Androgen-Related PatternsAP
You?
Average5.4
Typical rangeTypical3.4 – 7.5
Possible0 – 15
Menstrual-Cycle PatternsMP
You?
Average10.5
Typical rangeTypical8.3 – 12.7
Possible0 – 15
Metabolic and General-Health PatternsMaGP
You?
Average7
Typical rangeTypical4.7 – 9.3
Possible0 – 15
Featured On
SAMPLE QUESTIONS

Example Questions From the Test

    • I have not noticed bleeding between expected periods.
    • I noticed one brief episode of light spotting.
    • Spotting or bleeding has recurred between periods.
    • Unexpected bleeding has been heavy or accompanied by severe pain, weakness, dizziness, or possible pregnancy.
    • There is no known recurring loud snoring, gasping, or breathing interruption.
    • Occasional snoring has been mentioned, without gasping or daytime effects.
    • Loud snoring is frequent, or I regularly wake unrefreshed and struggle with daytime sleepiness.
    • Someone has observed repeated pauses, choking, or gasping, or I have dangerous sleepiness during activities such as driving.
    • I have not noticed a cluster of these changes.
    • One mild change has developed gradually.
    • Several changes have gradually become persistent.
    • Multiple changes developed quickly, or they include voice deepening or another marked physical change.
WHAT THE TEST MEASURES

PCOS Type Quiz - Description and methodology of the test

For people who notice possible PCOS-related changes, the PCOS Type Quiz offers a way to see which of three signal domains may merit attention. A PCOS symptom assessment can help show where tracking or follow-up may be useful, while keeping the focus on current patterns rather than a clinical label. It is especially useful when recent changes feel confusing, uneven, or difficult to describe clearly.

What This Assessment Explores

Possible signals are grouped into androgen-related changes, menstrual timing and bleeding, and broader metabolic or general-health patterns. Items cover acne, coarse hair, scalp thinning, skin changes, irregular cycles, unexpected bleeding, thirst, urination, weight change, post-meal symptoms, and sleep-breathing concerns.

Items ask whether changes are isolated, persistent, clustered, or rapidly developing; the result summarizes relevant bands. Here, “type” means a profile of current signals across three domains, not a validated clinical PCOS phenotype or subtype. This PCOS health questionnaire helps organize observations.

The three displayed scales are:

  • Androgen-Related Patterns (0-15) show No signal noted (0), Noted signal (1-2), or Follow-up signal (3-15) for androgen-related changes.
  • Menstrual-Cycle Patterns (0-15) show No signal (0), Noted signal (1-2), or Follow-up signal (3-15) for cycle and bleeding changes.
  • Metabolic and General-Health Patterns (0-15) show No signal noted (0), Noted signal (1-2), or Follow-up signal (3-15) for broader health signals.

Methodology and Evidence Base

Each prompt in this self-report questionnaire offers four ordered response choices, moving from no noticed pattern through mild or occasional change to persistent, marked, rapidly developing, or potentially urgent change. Questions add context through recurrence, duration, predictability, and speed of onset, rather than treating every endorsement as equivalent.

Results are reflective summaries, not validated severity, fertility, blood-sugar, cardiovascular, or clinical cutoffs. The questionnaire does not establish a universal point value for each option; a red-flag response scored 3 overrides the total, particularly with sudden physical changes, very heavy bleeding, breathing pauses, or severe metabolic symptoms.

Methodologically, the questionnaire is conceptually consistent with the 2023 International PCOS Guideline and can be read alongside the Rotterdam consensus and Endocrine Society guideline. These are clinical frameworks, not source scales adapted here. For a PCOS self-assessment, honest recall, medications, pregnancy status, life stage, and other conditions affect interpretation. A low band cannot rule out PCOS, while a follow-up band supports professional assessment; rapid or severe symptoms require prompt medical help.

Literature:
  • Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE, International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. European Journal of Endocrinology. 2023;189(2):G43-G64. 10.1093/ejendo/lvad096
  • The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19(1):41-47. 10.1093/humrep/deh098
  • Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2013;98(12):4565-4592. 10.1210/jc.2013-2350
Popular tests
Comments
Leave a Comment